Yishai Ofran

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Michael Heuser, Sylvie Freeman, Gert J. Ossenkoppele et al. · Blood · 2021 · 666 citations · Full text

Mixed-phenotype Acute Leukemia, Pathology, Measurable Residual Disease +16

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

Andrew H. Wei, Hartmut Döhner, Christopher Pocock et al. · New England Journal of Medicine · 2020 · 403 citations · Full text

Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Michael Heuser, Yishai Ofran, Nicolas Boissel et al. · Annals of Oncology · 2020 · 266 citations · Full text

Hematological Malignancy, Medicine, Adult Patients +7

Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death

Jessica K. Altman, Alfred Rademaker, Elizabeth H. Cull et al. · Leukemia Research · 2013 · 131 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +7

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Andrew H. Wei, Hartmut Döhner, Christopher Pocock et al. · Blood · 2019 · 97 citations